Gary L. Waldo

2.6k total citations
31 papers, 2.1k citations indexed

About

Gary L. Waldo is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Gary L. Waldo has authored 31 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 9 papers in Cell Biology and 6 papers in Physiology. Recurrent topics in Gary L. Waldo's work include Protein Kinase Regulation and GTPase Signaling (18 papers), Receptor Mechanisms and Signaling (11 papers) and Cellular transport and secretion (9 papers). Gary L. Waldo is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (18 papers), Receptor Mechanisms and Signaling (11 papers) and Cellular transport and secretion (9 papers). Gary L. Waldo collaborates with scholars based in United States, Japan and Germany. Gary L. Waldo's co-authors include T K Harden, T. Kendall Harden, José L. Boyer, John P. Perkins, John K. Northup, Andrew J. Morris, John Sondek, James Corbitt, C. Peter Downes and Erik T. Bodor and has published in prestigious journals such as Science, Chemical Reviews and Journal of Biological Chemistry.

In The Last Decade

Gary L. Waldo

31 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary L. Waldo United States 23 1.7k 554 418 315 214 31 2.1k
Daniele Zacchetti Italy 27 1.4k 0.8× 627 1.1× 375 0.9× 224 0.7× 385 1.8× 51 2.2k
Hideaki Ando Japan 22 1.9k 1.1× 441 0.8× 288 0.7× 181 0.6× 175 0.8× 37 2.6k
Shinichiro Toki Japan 13 1.3k 0.7× 362 0.7× 182 0.4× 91 0.3× 145 0.7× 28 1.9k
Iok-Hou Pang United States 21 1.5k 0.9× 265 0.5× 397 0.9× 89 0.3× 183 0.9× 40 2.4k
Eric Boursier France 2 1.6k 0.9× 436 0.8× 269 0.6× 85 0.3× 342 1.6× 2 2.4k
Tim Vervliet Belgium 20 1.1k 0.7× 199 0.4× 358 0.9× 189 0.6× 174 0.8× 43 1.6k
Frank Kalkbrenner Germany 23 1.5k 0.9× 801 1.4× 124 0.3× 78 0.2× 216 1.0× 32 2.1k
Tünde Golenár United States 10 1.7k 1.0× 398 0.7× 373 0.9× 108 0.3× 324 1.5× 15 2.0k
Mie Nakaya Japan 7 1.1k 0.6× 276 0.5× 165 0.4× 81 0.3× 115 0.5× 8 1.4k
Masami Yoshimura United States 28 1.4k 0.8× 631 1.1× 161 0.4× 79 0.3× 211 1.0× 62 2.0k

Countries citing papers authored by Gary L. Waldo

Since Specialization
Citations

This map shows the geographic impact of Gary L. Waldo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary L. Waldo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary L. Waldo more than expected).

Fields of papers citing papers by Gary L. Waldo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary L. Waldo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary L. Waldo. The network helps show where Gary L. Waldo may publish in the future.

Co-authorship network of co-authors of Gary L. Waldo

This figure shows the co-authorship network connecting the top 25 collaborators of Gary L. Waldo. A scholar is included among the top collaborators of Gary L. Waldo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary L. Waldo. Gary L. Waldo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Charpentier, Thomas H., Gary L. Waldo, Emily G. Lowery‐Gionta, et al.. (2016). Potent and Selective Peptide-based Inhibition of the G Protein Gαq. Journal of Biological Chemistry. 291(49). 25608–25616. 21 indexed citations
2.
Charpentier, Thomas H., Gary L. Waldo, Matthew O. Barrett, et al.. (2014). Membrane-induced Allosteric Control of Phospholipase C-β Isozymes. Journal of Biological Chemistry. 289(43). 29545–29557. 27 indexed citations
3.
Waldo, Gary L., Tiffany K. Ricks, Stephanie N. Hicks, et al.. (2010). Kinetic Scaffolding Mediated by a Phospholipase C–β and G q Signaling Complex. Science. 330(6006). 974–980. 164 indexed citations
4.
Bodor, Erik T., et al.. (2004). Delineation of ligand binding and receptor signaling activities of purified P2Y receptors reconstituted with heterotrimeric G proteins. Purinergic Signalling. 1(1). 43–49. 3 indexed citations
5.
Waldo, Gary L. & T. Kendall Harden. (2004). Agonist Binding and Gq-Stimulating Activities of the Purified Human P2Y1 Receptor. Molecular Pharmacology. 65(2). 426–436. 104 indexed citations
6.
Hooks, Shelley B., Gary L. Waldo, James Corbitt, et al.. (2003). RGS6, RGS7, RGS9, and RGS11 Stimulate GTPase Activity of Gi Family G-proteins with Differential Selectivity and Maximal Activity. Journal of Biological Chemistry. 278(12). 10087–10093. 130 indexed citations
7.
Bodor, Erik T., Gary L. Waldo, Shelley B. Hooks, et al.. (2003). Purification and Functional Reconstitution of the Human P2Y12 Receptor. Molecular Pharmacology. 64(5). 1210–1216. 64 indexed citations
8.
Waldo, Gary L., James Corbitt, José L. Boyer, et al.. (2002). Quantitation of the P2Y1 Receptor with a High Affinity Radiolabeled Antagonist. Molecular Pharmacology. 62(5). 1249–1257. 62 indexed citations
9.
Singer, Alex U., Gary L. Waldo, T. Kendall Harden, & John Sondek. (2001). A unique fold of phospholipase C-β mediates dimerization and interaction with Gαq. Nature Structural Biology. 9(1). 32–36. 84 indexed citations
10.
Waldo, Gary L., et al.. (2001). Protein Kinase C Phosphorylates RGS2 and Modulates Its Capacity for Negative Regulation of Gα11 Signaling. Journal of Biological Chemistry. 276(8). 5438–5444. 88 indexed citations
11.
Boyer, José L., Gary L. Waldo, & T. Kendall Harden. (1997). Molecular Cloning and Expression of an Avian G Protein-Coupled P2Y Receptor. Molecular Pharmacology. 52(6). 928–934. 40 indexed citations
12.
Waldo, Gary L., José L. Boyer, & T. Kendall Harden. (1994). [15] Purification of Phospholipase C-activating G protein, G11, from Turkey erythrocytes. Methods in enzymology on CD-ROM/Methods in enzymology. 237. 182–191. 6 indexed citations
13.
Waldo, Gary L., Andrew J. Morris, & T K Harden. (1994). [15] Purification of G-protein-regulated phospholipase C from Turkey erythrocytes. Methods in enzymology on CD-ROM/Methods in enzymology. 238. 195–207. 14 indexed citations
14.
Boyer, José L., Gary L. Waldo, & T K Harden. (1992). Beta gamma-subunit activation of G-protein-regulated phospholipase C.. Journal of Biological Chemistry. 267(35). 25451–25456. 161 indexed citations
16.
Harden, T. Kendall, Andrew J. Morris, Gary L. Waldo, C. Peter Downes, & José L. Boyer. (1991). Avian G-protein-regulated phospholipase C. Biochemical Society Transactions. 19(2). 342–346. 4 indexed citations
18.
Toews, M L, et al.. (1986). Comparison of binding of 125I-iodopindolol to control and desensitized cells at 37 degrees and on ice.. PubMed. 11(1). 47–62. 6 indexed citations
19.
Waldo, Gary L., Robert C. Doss, John P. Perkins, & T K Harden. (1984). Use of a density shift method to assess beta-adrenergic receptor synthesis during recovery from catecholamine-induced down-regulation in human astrocytoma cells.. Molecular Pharmacology. 26(3). 424–429. 12 indexed citations
20.
Waldo, Gary L., John K. Northup, John P. Perkins, & T K Harden. (1983). Characterization of an altered membrane form of the beta-adrenergic receptor produced during agonist-induced desensitization.. Journal of Biological Chemistry. 258(22). 13900–13908. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026